coly11
@coly11.bsky.social
Canadian passionate about STEM, economy, politic and democracy. ♦Imagine a peaceful World where we can live together without fear, without violence, and without discrimination♦
CRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3 drop in Phase 1 CTX310 trial
November 9, 2025 at 7:54 PM
CRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3 drop in Phase 1 CTX310 trial
Reposted by coly11
